3.64
3.70%
-0.14
시간 외 거래:
3.66
0.02
+0.55%
AbCellera Biologics Inc 주식(ABCL)의 최신 뉴스
AbCellera Stock: If You Build It, Will They Come? Fresh Impetus Required (NASDAQ:ABCL) - Seeking Alpha
Seeking Alpha
AbCellera Stock: Cash Providing Shelter From Market Weakness (NASDAQ:ABCL) - Seeking Alpha
Seeking Alpha
Q2 2024 Earnings Forecast for AbCellera Biologics Inc. Issued By Bloom Burton (NASDAQ:ABCL) - MarketBeat
MarketBeat
Bloom Burton Weighs in on AbCellera Biologics Inc.'s Q2 2024 Earnings (NASDAQ:ABCL) - Defense World
Defense World
AbCellera Biologics Inc. to Post FY2026 Earnings of ($0.67) Per Share, Bloom Burton Forecasts (NASDAQ:ABCL) - Defense World
Defense World
AbCellera Biologics (ABCL) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
Leerink Partnrs Comments on AbCellera Biologics Inc.'s Q2 2024 Earnings (NASDAQ:ABCL) - Defense World
Defense World
AbCellera Biologics Inc. (NASDAQ:ABCL) Expected to Earn FY2026 Earnings of ($0.67) Per Share - MarketBeat
MarketBeat
Earnings Release: Here's Why Analysts Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$12.71 - Yahoo Finance
Yahoo Finance
AbCellera Biologics (NASDAQ:ABCL) Price Target Lowered to $7.00 at KeyCorp - Defense World
Defense World
KeyBanc lowers AbCellera Biologics shares target amid growth transition - Investing.com South Africa
Investing.com South Africa
AbCellera Biologics (NASDAQ:ABCL) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
MarketBeat
AbCellera Biologics (NASDAQ:ABCL) PT Lowered to $7.00 - MarketBeat
MarketBeat
KeyBanc lowers AbCellera Biologics shares target amid growth transition - Investing.com Canada
Investing.com Canada
KeyBanc lowers AbCellera Biologics shares target amid growth transition - Investing.com
Investing.com
AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
The Motley Fool
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Lifestyle UK
Yahoo Lifestyle UK
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript - The Globe and Mail
The Globe and Mail
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Yahoo Finance
AbCellera Biologics Inc (ABCL) Q1 2024 Earnings: Misses Revenue and Net Loss Estimates - Yahoo Finance
Yahoo Finance
AbCellera Reports Q1 2024 Business Results - 07.05.2024 - wallstreet:online
wallstreet:online
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Yahoo Finance
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Lags Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Strong week for AbCellera Biologics (NASDAQ:ABCL) shareholders doesn't alleviate pain of one-year loss - Yahoo Movies Canada
Yahoo Movies Canada
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo News Australia
Yahoo News Australia
AbCellera Biologics Inc. (NASDAQ:ABCL) Receives $15.86 Average PT from Analysts - Defense World
Defense World
Venture report: Rounds for psychedelic play Reunion, cancer company Delphia - BioCentury
BioCentury
Insider Stock Buying Reaches US$1.61m On AbCellera Biologics - Yahoo Finance
Yahoo Finance
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks Investment Research
AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies - Business Wire
Business Wire
AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
MarketBeat
AbCellera partners with PE firms to develop antibody drugs, company creation - Seeking Alpha
Seeking Alpha
Vancouver biotech company plans $701M expansion, with $300M coming from government - Grand Forks Gazette
Grand Forks Gazette
Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
AbCellera Biologics (ABCL) to Release Earnings on Tuesday - MarketBeat
MarketBeat
Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance Australia
Yahoo Finance Australia
In the wake of AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest US$91m market cap drop, institutional owners may be forced to take severe actions - Simply Wall St
Simply Wall St
AbCellera advances T-cell cancer therapy with new data - Investing.com Nigeria
Investing.com Nigeria
AbCellera advances T-cell cancer therapy with new data - Investing.com Canada
Investing.com Canada
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 - Yahoo Finance
Yahoo Finance
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 - Yahoo Finance
Yahoo Finance
Combining ADCs with protein degraders could widen the therapeutic windows of both - BioCentury
BioCentury
Bearish bets, torpedo stocks and short squeezes on the TSX - The Globe and Mail
The Globe and Mail
AbCellera and Biogen link on neurological antibody therapy - Pharmaceutical Technology
Pharmaceutical Technology
Abcellera To Collaborate With Biogen To Discover Therapeutic Antibodies For Neurological Conditions - XM
XM
Vancouver readies for its position as a global pharma capital as B.C.'s biotech boom takes off - The Globe and Mail
The Globe and Mail
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 - Business Wire
Business Wire
AbCellera Biologics Insiders Added US$1.61m Of Stock To Their Holdings - Simply Wall St
Simply Wall St
AbCellera: Victim Of Its Own Success (NASDAQ:ABCL) - Seeking Alpha
Seeking Alpha
자본화:
|
볼륨(24시간):